Epilepsy Epidiolex denied for failing step therapy by Cigna?
Step-therapy denials usually flip when the appeal documents that prior alternatives were tried and failed, or were contraindicated, or aren't safe for the patient.
US health-plan appeal rights
Cite: Most US health plans have appeal rights under either the ACA, ERISA, or Medicare/Medicaid rules
Most US health plans are required by federal law to give you both an internal appeal (where the insurer reconsiders) and an external review (where an independent reviewer decides). The exact timelines and processes depend on what kind of plan you have — marketplace / employer group, self-funded, Medicare Advantage, or Medicaid MCO — but in every case there's a window after the denial during which you have the right to fight it.
What Cigna typically requires
Cigna's specific coverage criteria for epilepsy epidiolex are defined in its own published medical/coverage policy and the FDA-approved prescribing label. A successful appeal documents that your medical records satisfy each criterion those sources list — confirmed diagnosis, any required prior treatments (with dates and outcomes), and clinical severity. If the exact criteria weren't included with your denial, request them in writing; your appeal then maps each requirement to the matching fact in your chart.
The Cigna angle on Epilepsy Epidiolex
## Why Cigna Requires Step Therapy Before Epidiolex — and How to Override It
Epidiolex (cannabidiol) is an FDA-approved treatment for certain severe, treatment-resistant epilepsy syndromes. Cigna's step-therapy requirement means the plan expects documentation that a defined number and type of other anti-seizure medications (ASMs) were tried and did not provide adequate seizure control before Epidiolex will be covered. This requirement exists because ASMs vary significantly in cost, and payers try to ensure lower-cost options were considered first. However, the step-therapy protocol can be overridden when the clinical record shows the required steps have already been completed — which, for most Epidiolex patients, they have.
## Why This Denial Is Appealable
Step-therapy denials for Epidiolex are among the most commonly overturned, because the patients for whom Epidiolex is indicated have virtually always been through extensive prior treatment. If your medical record documents a history of multiple ASMs tried and failed — with dates, durations, and outcomes — the clinical case for step-therapy override is strong. Additionally, many states have enacted step-therapy override laws requiring insurers to grant exceptions when step-therapy drugs were previously tried, were contraindicated, or would cause clinically significant harm.
## Your Federal Appeal Rights
- Internal appeal: ACA §2719 and ERISA §503 guarantee a full-and-fair internal review. Submit your appeal within the deadline on your denial notice.
- External review: If the internal appeal is upheld, you have approximately four months to request independent external review by an IRO. Neurology-credentialed reviewers frequently overturn step-therapy denials for rare epilepsy syndromes.
- Expedited review: If enforcing the step-therapy requirement would delay treatment while the patient has frequent or dangerous seizures, request expedited review for a 72-hour decision.
## Documentation to Gather
1. Complete prior ASM history: A chronological list of every anti-seizure medication previously tried — drug names, start and end dates, duration of use, highest dose reached per the prescriber's chart, and the specific reason each was stopped (inadequate seizure control, intolerable adverse effects, or both). 2. Reason prior steps are complete or inapplicable: If Cigna's required step drugs were tried (most likely), document that clearly. If any required drug is medically inappropriate for this patient's specific syndrome, the neurologist should explain why. 3. Seizure frequency and severity records: A seizure diary or chart summary showing ongoing uncontrolled seizures despite prior treatments. 4. Epilepsy syndrome diagnosis confirmation: EEG reports, genetic testing, imaging, and specialist notes confirming the specific diagnosis and its treatment-resistant nature. 5. Prescriber step-therapy override letter: A letter from the treating neurologist or epileptologist explicitly requesting a step-therapy exception, listing each required prior step and its outcome, and explaining why Epidiolex is now the clinically appropriate treatment.
## Criteria-Mapping Structure
Obtain Cigna's Epidiolex step-therapy requirements from their coverage policy portal:
| Step-Therapy Requirement | Clinical Evidence | |---|---| | [Required ASM 1] tried and failed | [Chart note with dates, duration, outcome] | | [Required ASM 2] tried and failed | [Chart note with dates, duration, outcome] | | Additional required steps | [Documented per chart or contraindication explained] | | Ongoing uncontrolled seizures | [Seizure log or chart summary] | | Specialist prescriber attestation | [Neurologist/epileptologist letter] |
Mapping your history directly to each required step in the letter is the single most effective way to obtain step-therapy override approval.
Next steps
- Find the date on the denial letter — your appeal window starts there.
- Read your plan's Summary of Benefits and Coverage (SBC) for the specific deadlines.
- Request the insurer's claim file in writing — they must provide it.
- Submit your appeal in writing with new clinical evidence and a physician statement.
Get the letter drafted
DenialHelp drafts your appeal in 5 minutes — $40 list price, $30 for your first letter (use code SEO25). We cite the federal regs and the specific clinical evidence your plan responds to. Your physician signs and sends.
Start my appeal — $30 with code SEO25 →